Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Diagnostic Accuracy of CYFRA21-1 in the Differential Diagnosis of Pleural Effusions.

Trapé J, Sant F, Montesinos J, Arnau A, Sala M, Bernadich O, Martín E, Perich D, Lopez J, Ros S, Esteve-Valverde E, Pérez R, González-Fernández C, Aligue J, Catot S, Domenech M, Ruiz D, Bonet M, Molina R, Ordeig J.

Anticancer Res. 2019 Sep;39(9):5071-5076. doi: 10.21873/anticanres.13700.

PMID:
31519617
2.

Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Trapé J, Sant F, Franquesa J, Montesinos J, Arnau A, Sala M, Bernadich O, Martín E, Perich D, Pérez C, Lopez J, Ros S, Esteve E, Pérez R, Aligué J, Gurt G, Catot S, Domenech M, Bosch J, Badal JM, Bonet M, Molina R, Ordeig J.

Respir Res. 2017 May 25;18(1):103. doi: 10.1186/s12931-017-0582-1.

3.

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P.

Anticancer Res. 2016 Dec;36(12):6647-6653.

PMID:
27919997
4.

Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma.

Sánchez Hernández A, José Juan O, Vidal Martínez J, Blanco R, Maciá S, Esquerdo Galiana G, Aparisi Aparisi F, Garde Noguera J, Catot S, Losa Gaspá F, García-Piñon F.

Clin Transl Oncol. 2015 Apr;17(4):281-8. doi: 10.1007/s12094-014-1223-5. Epub 2014 Sep 19.

PMID:
25236392
5.

A prognostic score based on clinical factors and biomarkers for advanced non-small cell lung cancer.

Trapé J, Montesinos J, Catot S, Buxó J, Franquesa J, Sala M, Domenech M, Sant F, Badal JM, Arnau A.

Int J Biol Markers. 2012 Oct 8;27(3):e257-62. doi: 10.5301/JBM.2012.9314.

PMID:
22815214
6.

Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study.

Oaknin A, Roda D, González-Martín A, Chiva L, García-Donas J, de Juan A, Redondo A, Martínez S, García Y, Catot S, Ponce J, Del Campo JM, Cervantes A, Poveda A.

Int J Gynecol Cancer. 2011 Aug;21(6):1048-55. doi: 10.1097/IGC.0b013e31821ee777.

PMID:
21738038
7.

Determination of biological variation of α-fetoprotein and choriogonadotropin (β chain) in disease-free patients with testicular cancer.

Trapé J, Franquesa J, Sala M, Domenech M, Montesinos J, Catot S, Buxó J, Casado E, Fígols C, Harillo S, Galobart J, Bella M.

Clin Chem Lab Med. 2010 Dec;48(12):1799-801. doi: 10.1515/CCLM.2010.343. Epub 2010 Sep 10.

PMID:
20828364
8.

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

Porta R, Sánchez-Torres JM, Paz-Ares L, Massutí B, Reguart N, Mayo C, Lianes P, Queralt C, Guillem V, Salinas P, Catot S, Isla D, Pradas A, Gúrpide A, de Castro J, Polo E, Puig T, Tarón M, Colomer R, Rosell R.

Eur Respir J. 2011 Mar;37(3):624-31. doi: 10.1183/09031936.00195609. Epub 2010 Jul 1.

9.

Screening for epidermal growth factor receptor mutations in lung cancer.

Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group.

N Engl J Med. 2009 Sep 3;361(10):958-67. doi: 10.1056/NEJMoa0904554. Epub 2009 Aug 19.

10.

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

Rosell R, Perez-Roca L, Sanchez JJ, Cobo M, Moran T, Chaib I, Provencio M, Domine M, Sala MA, Jimenez U, Diz P, Barneto I, Macias JA, de Las Peñas R, Catot S, Isla D, Sanchez JM, Ibeas R, Lopez-Vivanco G, Oramas J, Mendez P, Reguart N, Blanco R, Taron M.

PLoS One. 2009;4(5):e5133. doi: 10.1371/journal.pone.0005133. Epub 2009 May 5.

12.

Applications of genomics in NSCLC.

Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O.

Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Review.

PMID:
16557672
13.

Applications of genomics in NSCLC.

Rosella R, Cobo M, Isla D, Miguel Sanchez J, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniza O.

Lung Cancer. 2005 Dec;50S2:S33-S40.

PMID:
16551521
14.

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.

Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de Las Peñas R, Sanchez JM, Moran T, Camps C, Massuti B, Sanchez JJ, Salazar F, Catot S; Spanish Lung Cancer Group.

J Clin Oncol. 2005 Dec 20;23(36):9105-12.

PMID:
16361617

Supplemental Content

Support Center